E-prescribing, also known as electronic prescribing, is a method of prescribing medication that involves the use of electronic devices, such as computers or smartphones, to transmit prescription orders from healthcare providers to pharmacies. When using e-prescribing, the healthcare provider can quickly and easily access the patient’s medication history, which helps to identify potential drug interactions, allergies, or other issues that could cause harm to the patient. This results in increased patient safety and improved health outcomes. E-prescribing also offers improved convenience and efficiency for both the healthcare provider and the patient. Healthcare providers can prescribe medication from any location with an internet connection, and patients can have their prescriptions filled at any pharmacy that accepts electronic prescriptions. This eliminates the need for patients to wait in line at the pharmacy or for healthcare providers to spend time calling in prescriptions, resulting in improved patient satisfaction and faster medication delivery. The global e-prescribing market is likely to register a CAGR of over 23.9% 米ドルの漸進的な成長に伴い 6.9 予測期間中に10億ドル 2023-2029.

レポートは市場規模と成長をカバーしています, セグメンテーション, 地域内訳, 競争環境, trends and strategies for global e-prescribing market. 利害関係者が現在の市場機会を活用できるように、市場の定量的な分析を提供します。. このレポートはまた、市場動向と主要な競合他社のアプローチに基づいて、機会と戦略の上位セグメントを特定します。.

この業界レポートは、世界市場の市場推定と予測を提供します。, その後、製品の詳細な分析が行われます, delivery mode, specialties, エンドユーザー, usage method, substance, と地域. The global market for e-prescribing can be segmented by product: ソリューション, サービス. The solutions segment is estimated to account for the largest share of the global e-prescribing market. E-prescribing market is further segmented by delivery mode: web/cloud based, 前提について. The web/cloud based segment held the largest revenue share in 2022. Based on specialties, the e-prescribing market is segmented into: 腫瘍学, sports medicines, 神経学, 心血管系, その他. 世界的に, the sports medicines segment made up the largest share of the e-prescribing market. エンドユーザーベース, the e-prescribing market also can be divided into: 病院, office-based physicians, 薬局, その他. The hospital segment was the largest contributor to the global e-prescribing market in 2022. E-prescribing market by usage method is categorized into: hand-held, computer based devices. The e-prescribing market by substance can be segmented into: controlled, non- controlled. 地域に基づく, the e-prescribing market is further categorized into: 北米, ヨーロッパ, アジア太平洋地域, もの (中東とアフリカ), ラテンアメリカ.

市場セグメンテーション
製品別: ソリューション, サービス
By delivery mode: web/cloud based, 前提について
By specialties: 腫瘍学, sports medicines, 神経学, 心血管系, その他
エンドユーザー別: 病院, office-based physicians, 薬局, その他
By usage method: hand-held, computer based devices
By substance: controlled, non- controlled
地域別: 北米, ヨーロッパ, アジア太平洋地域, もの (中東とアフリカ), ラテンアメリカ

The market research report covers the analysis of key stake holders of the global e-prescribing market. Some of the leading players profiled in the report include Allscripts Healthcare Solution Inc., Athenahealth, 株式会社, Cerner Corporation, Epic Systems Corporation, ゼネラル・エレクトリック社, McKesson Corporation, NextGen Healthcare, 株式会社, SureScripts LLC, とりわけ. このレポートでは, 市場の競争見通しを理解するために、主要なプレーヤーとその戦略を徹底的に分析します。.
*無料サンプルをリクエストして企業の完全なリストを入手してください

報告書の範囲
• To analyze and forecast the market size of the global e-prescribing market.
• To classify and forecast the global e-prescribing market based on product, delivery mode, specialties, エンドユーザー, usage method, substance, 領域.
• To identify drivers and challenges for the global e-prescribing market.
• 合併などの競争展開を検討するため & 買収, 協定, コラボレーションとパートナーシップ, 等, in the global e-prescribing market.
• To identify and analyze the profile of leading players operating in the global e-prescribing market.

このレポートを選択する理由
• Gain a reliable outlook of the global e-prescribing market forecasts from 2023 に 2029 シナリオ全体にわたって.
• 投資対象となる成長セグメントを特定する.
• 会社概要と市場データを通じて競合他社に先んじる.
• Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
• 3ヶ月間の戦略コンサルティングとリサーチサポート.
• シングルユーザーライセンスに提供される印刷認証.